Premium
National cancer prevalence estimation in France
Author(s) -
Colonna Marc,
Hedelin Guy,
Esteve Jacques,
Grosclaude Pascale,
Launoy Guy,
Buemi Antoine,
Arveux Patrick,
Tretarre Brigitte,
Chaplain Gilles,
Lesec'h Josette Mace,
Raverdy Nicole,
Marie Carli Paule,
Menegoz François,
Faivre Jean
Publication year - 2000
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/1097-0215(20000715)87:2<301::aid-ijc24>3.0.co;2-y
Subject(s) - epidemiology , medicine , incidence (geometry) , cancer , demography , estimation , danish , breast cancer , cancer registry , head and neck , prostate cancer , surgery , linguistics , philosophy , physics , management , sociology , optics , economics
In France, as in several other European countries, prevalence has to be estimated from the modelling of 2 of the 3 basic epidemiological measures of incidence, mortality, and survival. Since, in these countries, follow‐up of cancer patients is only made in a few registries, we explored the feasibility of estimating prevalence in the absence of follow‐up data. The method, which used only incidence and mortality, was validated on Danish data and applied to France. For this latter country, the estimation procedure is based on the recorded mortality data and an estimate of incidence for the entire country. It is applied to selected sites of cancer, which account for 80% of the estimated incidence. In 1992, the prevalence of patients who had such a diagnosis amounts to 538,000 women and 424,000 men. The most frequent cancer sites are head and neck, breast, and large bowel. Most of the cancer sites present an increase in prevalence proportion between 1987 and 1992. The larger increases concern breast and prostate cancer. Int. J. Cancer 87:301–304, 2000. © 2000 Wiley‐Liss, Inc.